YIELD10 BIOSCIENCE, INC.·4

Jan 13, 4:30 PM ET

HAASER CHARLES B 4

4 · YIELD10 BIOSCIENCE, INC. · Filed Jan 13, 2023

Insider Transaction Report

Form 4
Period: 2023-01-12
HAASER CHARLES B
Chief Accounting Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-12+18,00018,000 total
    Exercise: $3.15Exp: 2033-01-12Common Stock (18,000 underlying)
Footnotes (1)
  • [F1]These options will vest and become exercisable in equal quarterly installments over 4 years from 1/12/2023, beginning on 4/12/2023 and ending on 1/12/2027.

Documents

1 file
  • 4
    wf-form4_167364538464437.xmlPrimary

    FORM 4